Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInvested CapitalMarket CapitalizationNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on SalesTimes Interest Earned

Neurogene (NGNE) Operating Margin: 2019-2025

Historic Operating Margin for Neurogene (NGNE) over the last 3 years, with Sep 2025 value amounting to 56,661.90%.

  • Neurogene's Operating Margin fell 6007494.00% to 56,661.90% in Q3 2025 from the same period last year, while for Sep 2025 it was 15,952.46%, marking a year-over-year increase of 947714.00%. This contributed to the annual value of -8,930.27% for FY2024, which is 20744098.00% down from last year.
  • According to the latest figures from Q3 2025, Neurogene's Operating Margin is 56,661.90%, which was up 60.77% from 35,244.59% recorded in Q2 2025.
  • In the past 5 years, Neurogene's Operating Margin ranged from a high of 434,500.00% in Q1 2023 and a low of 3,119.44% during Q1 2024.
  • For the 3-year period, Neurogene's Operating Margin averaged around 133,606.80%, with its median value being 56,661.90% (2025).
  • As far as peak fluctuations go, Neurogene's Operating Margin plummeted by 43,138,056bps in 2024, and later soared by 3,146,711bps in 2025.
  • Quarterly analysis of 3 years shows Neurogene's Operating Margin stood at 86,664.71% in 2023, then crashed by 8,146,857bps to 5,196.14% in 2024, then plummeted by 6,007,494bps to 56,661.90% in 2025.
  • Its Operating Margin was 56,661.90% in Q3 2025, compared to 35,244.59% in Q2 2025 and 32,398.75% in Q1 2025.